Neuroimaging of central breathlessness mechanisms

Current Opinion in Supportive and Palliative Care

Volumn 8, Issue 3, 2014, Pages 225-233

  Pattinson, Kyle T S ^a   Johnson, Miriam J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Breathlessness; Functional MRI; Magnetoencephalography; Neuroimaging

Indexed keywords

BRAIN; DYSPNEA; EMOTION; HUMAN; MAGNETOENCEPHALOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOPHYSIOLOGY; PROCEDURES;

BRAIN; DYSPNEA; EMOTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; NEUROIMAGING; PAIN;

EID: 84905740104     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0000000000000069     Document Type: Review

References (52)

1. Johnson MJ, Bowden JA, Abernethy AP, Currow DC. To what causes do people attribute their chronic breathlessness? A population survey. J Palliat Med 2012; 15:744-750.
2. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56:880-887.
3. Hayen A, Herigstad M, Pattinson KT. Understanding dyspnea as a complex individual experience. Maturitas 2013; 76:45-50.
4. Pratter MR, Abouzgheib W, Akers S, et al. An algorithmic approach to chronic dyspnea. Respir Med 2011; 105:1014-1021.
5. Booth S, Bausewein C, Higginson I, Moosavi SH. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 2009; 3:21-36.
6. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185:435-452.
7. Pattinson KT. Functional magnetic resonance imaging in anaesthesia research. Br J Anaesth 2013; 111:872-876.
8. Hayen A, Herigstad M, Kelly M, et al. The effects of altered intrathoracic pressure on resting cerebral blood flow and its response to visual stimulation. NeuroImage 2012; 66C:479-488.
9. Wise RG, Pattinson KT, Bulte DP, et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J Cereb Blood Flow Metab 2007; 27:1521-1532.
10. Masamoto K, Kanno I. Anesthesia and the quantitative evaluation of neurovascular coupling. J Cereb Blood Flow Metab 2012; 32:1233-1247.
11. Pattinson KT, Rogers R, Mayhew SD, et al. Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia. J Cereb Blood Flow Metab 2007; 27:414-423.
12. Mogi M, Horiuchi M. Neurovascular coupling in cognitive impairment associated with diabetes mellitus. Circ J 2011; 75:1042-1048.
13. Brooks JC, Faull OK, Pattinson KT, Jenkinson M. Physiological noise in brainstem FMRI. Front Hum Neurosci 2013; 7:623.
14. Harvey AK, Pattinson KT, Brooks JC, et al. Brainstem functional magnetic resonance imaging: disentangling signal from physiological noise. J Magn Reson Imaging 2008; 28:1337-1344.
15. Pattinson KT, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci 2009; 29:8177-8186.
16. Diukova A, Ware J, Smith JE, et al. Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses. NeuroImage 2012; 62:239-249.
17. Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest 2013; 143: 1436-1443.
18. White JA, Patel MR. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin 2007; 25:71-95; vi.
19. Gore JC. Principles and practice of functional MRI of the human brain. J Clin Invest 2003; 112:4-9.
20. Proudfoot M, Woolrich MW, Nobre AC, Turner MR. Magnetoencephalography. Pract Neurol 2014; 0:1-8. doi:10.1136/practneurol-2013-000768.
21. Hari R, Parkkonen L, Nangini C. The brain in time: insights from neuromagnetic recordings. Ann N Y Acad Sci 2010; 1191:89-109.
22. Liotti M, Brannan S, Egan G, et al. Brain responses associated with consciousness of breathlessness (air hunger). Proc Natl Acad Sci USA 2001; 98:2035-2040.
23. Brannan S, Liotti M, Egan G, et al. Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air. Proc Natl Acad Sci USA 2001; 98:2029-2034.
24. Parsons LM, Egan G, Liotti M, et al. Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air. Proc Natl Acad Sci USA 2001; 98:2041-2046.
25. Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neuroreport 2000; 11:2117-2120.
26. Peiffer C, Poline JB, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163:951-957.
27. Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002; 88:1500-1511.
28. Peiffer C, Costes N, Herve P, Garcia-Larrea L. Relief of dyspnea involves a characteristic brain activation and a specific quality of sensation. Am J Respir Crit Care Med 2008; 177:440-449.
29. Von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008; 177:1026-1032.
30. Von Leupoldt A, Sommer T, Kegat S, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma. Am J Respir Crit Care Med 2009; 180:232-238.
31. Von Leupoldt A, Sommer T, Kegat S, et al. Dyspnea and pain share emotionrelated brain network. NeuroImage 2009; 48:200-206.
32. Herigstad M, Hayen A, Wiech K, Pattinson KT. Dyspnoea and the brain. Respir Med 2011; 105:809-817.
33. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 2007; 55:377-391.
34. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167:53-60.
35. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012; 141:1546-1553.
36. Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011; 140:618-625.
37. Pappens M, Smets E, Vansteenwegen D, et al. Learning to fear suffocation: a new paradigm for interoceptive fear conditioning. Psychophysiology 2012; 49:821-828.
38. Johnson MJ, Bland JM, Oxberry SG, et al. Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J 2013; 42:758-766.
39. Johnson MJ, Abernethy AP, Currow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan? J Pain Symptom Manage 2012; 43:614-624.
40. Baumblatt JA, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med 2014; 174:796-801. doi:10.1001/jamainternmed.2013.12711.
41. Society TBP. Opioids for persistent pain: good practice. London: The British Pain Society; 2010.
42. Pattinson KT. Opioids and the control of respiration. Br J Anaesth 2008; 100:747-758.
43. Farrell PA, Kjaer M, Bach FW, Galbo H. Beta-endorphin and adrenocorticotropin response to supramaximal treadmill exercise in trained and untrained males. Acta Physiol Scand 1987; 130:619-625.
44. Sgherza AL, Axen K, Fain R, et al. Effect of naloxone on perceived exertion and exercise capacity during maximal cycle ergometry. J Appl Physiol 1985-2002; 93:2023-2028.
45. Mahler DA, Murray JA, Waterman LA, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009; 33:771-777.
46. Jones AK, Kitchen ND, Watabe H, et al. Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography. J Cereb Blood Flow Metab 1999; 19:803-808.
47. Jones AK, Cunningham VJ, Ha-Kawa S, et al. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. Br J Rheumatol 1994; 33:909-916.
48. Price DD, Von der Gruen A, Miller J, et al. A psychophysical analysis of morphine analgesia. Pain 1985; 22:261-269.
49. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293:311-315.
50. Oertel BG, Preibisch C, Wallenhorst T, et al. Differential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther 2008; 83:577-588.
51. Pattinson KT, Mitsis GD, Harvey AK, et al. Determination of the human brainstem respiratory control network and its cortical connections in vivo using functional and structural imaging. NeuroImage 2009; 44:295-305.
52. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioidinduced respiratory depression. Anesthesiology 2010; 112:226-238.